598. Is Overconsolidation a Threat to Democracy?

That’s the worry. Even the humble eyeglass industry is dominated by a single firm. 

We look into the global spike in myopia, how the Lemtosh got its name, and what your eye doctor knows that you don’t. (Part two of a two-part series.)

 

SOURCES:Maria Liu, professor of clinical optometry at the University of California, Berkeley.Harvey Moscot, C.E.O. of MOSCOT Eyewear and Eyecare.Zachary Moscot, chief design officer of MOSCOT Eyewear and Eyecare.Cédric Rossi, equity research analyst at Bryan Garnier.Tim Wu, professor of law, science and technology at Columbia Law School.

 

RESOURCES:"Meta in Talks to Buy Stake in Eyewear Giant EssilorLuxottica," by Salvador Rodriguez and Lauren Thomas (The Wall Street Journal, 2024)."The Story Behind Soaring Myopia Among Kids," by Manoush Zomorodi, Katie Monteleone, Sanaz Meshkinpour, and Rachel Faulkner White (Body Electric, 2024)."Why So Many People Need Glasses Now," by Christophe Haubursin (Vox, 2023)."Eyes on World Sight: Taking Action to Advance Eye Health in China," by EssilorLuxottica (2022)."Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050," by Brien A. Holden, Timothy R. Fricke, Serge Resnikoff, et al. (Ophthalmology, 2016)."Increased Prevalence of Myopia in the United States Between 1971-1972 and 1999-2004," by Susan Vitale, Robert D. Sperduto, and Frederick L. Ferris (Archives of Ophthalmology, 2009).

 

EXTRAS:"The Economics of Eyeglasses," series by Freakonomics Radio (2024).